Author

M. Ribeiro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Ecology· 1 Pathology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

A. Belhadef· 1 shared A. Keuroghlian· 1 shared A. Llach· 1 shared A. M. Coimbra· 1 shared A. Rodgers· 1 shared A.-M. Gomez· 1 shared B. Crozatier· 1 shared B. Strickland· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Belhadef

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Metformin disrupts Danio rerio metabolism at environmentally relevant concentrations: A generational study

S. Barros, M. Ribeiro, A. M. Coimbra, M. Pinheiro, H. Morais, N. Alves, R. Montes, R. Rodil, J. B. Quintana, M. M. Santos, T. Neuparth

This study shows that metformin disrupts zebrafish metabolism at environmentally relevant concentrations, affecting lipid homeostasis and mitochondrial function across generations.

bioRxiv · Apr 5, 2022 · PreprintPharmacology & Toxicology

GPR183 mediates the capacity of the novel CD47-CD19 bispecific antibody TG-1801 to heighten ublituximab-umbralisib (U2) anti-lymphoma activity

M. Ribeiro, N. Profitos-Peleja, J. C. Santos, P. Blecua, D. Reyes Garau, M. Armengol, M. Fernandez-Serrano, H. P. Miskin, F. Bosch, M. Esteller, E. Normant, G. Roue

This study shows that TG-1801 enhances ublituximab's anti-lymphoma activity through GPR183-mediated mechanisms in B-NHL models.

bioRxiv · Mar 31, 2022 · PreprintCancer Biology

EPAC1 Inhibition Protects the Heart from Doxorubicin-Induced Toxicity

M. Mazevet, A. Belhadef, M. Ribeiro, D. Dayde, A. Llach, M. Laudette, T. Belleville, P. Mateo, M. Gressette, F. Lefebvre, J. Chen, C. Bachelot-Loza, C. Rucker-Martin, F. Lezoualch, B. Crozatier, , E. Morel

This study shows that inhibiting EPAC1 protects the heart from doxorubicin-induced toxicity without affecting its cancer-killing effects.

bioRxiv · Jun 16, 2021Pathology

Solving the Sample Size Problem for Resource Selection Analysis

G. M. Street, J. R. Potts, L. Borger, J. Beasley, S. Demarais, J. M. Fryxell, P. McLoughlin, K. Monteith, C. Prokopenko, M. Ribeiro, A. Rodgers, B. Strickland, F. Van Beest, D. Bernasconi, L. Beumer, , E. Vander Wal

This paper provides mathematical expressions to determine optimal sample sizes for resource selection analyses, showing that fewer data may be sufficient for strong selection effects.

bioRxiv · Feb 22, 2021 · PreprintEcology

Towards understanding cancer stem cell heterogeneity in the tumor microenvironment

F. Bocci, L. Gearhart-Serna, M. Boareto, M. Ribeiro, E. Ben-Jacob, G. R. Devi, H. Levine, J. N. Onuchic, M. K. Jolly

This paper develops a computational-experimental framework to explain the spatial heterogeneity of cancer stem cells in the tumor microenvironment, showing that Notch-JAG1 signaling and inflammatory cytokines drive CSC distribution and stemness.

bioRxiv · Sep 5, 2018Cancer Biology